Clinical Utility of Liquid Biopsy After Progression to First and Second-Generation TKIs in Advanced EGFR Mutant NSCLC Patients-MedSci.cn

Clinical Utility of Liquid Biopsy After Progression to First and Second-Generation TKIs in Advanced EGFR Mutant NSCLC Patients

Heredia, D; Lara-Mejia, L; Cruz-Rico, G; Valencia-Velarde, A; Cardenas-Fernandez, D; Bolano-Guerra, L; Varela-Santoyo, E; Orozco, M; Cabrera-Miranda, L; Ramos-Ramirez, M; Arrieta, O

JOURNAL OF THORACIC ONCOLOGY, 2022; 17 (9): S413

科室
- - 订阅+
  - 更多科室
工具
服务